Rights and permissions
About this article
Cite this article
Irbesartan cost effective in diabetic nephropathy with hypertension. Pharmacoecon. Outcomes News 429, 5 (2003). https://doi.org/10.1007/BF03276748
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03276748